GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (FRA:87S) » Definitions » Gross Margin %

Roivant Sciences (FRA:87S) Gross Margin % : 92.78% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Roivant Sciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Roivant Sciences's Gross Profit for the three months ended in Jun. 2024 was €47.5 Mil. Roivant Sciences's Revenue for the three months ended in Jun. 2024 was €51.2 Mil. Therefore, Roivant Sciences's Gross Margin % for the quarter that ended in Jun. 2024 was 92.78%.


The historical rank and industry rank for Roivant Sciences's Gross Margin % or its related term are showing as below:

FRA:87S' s Gross Margin % Range Over the Past 10 Years
Min: 78.58   Med: 85.66   Max: 91.36
Current: 90.32


During the past 4 years, the highest Gross Margin % of Roivant Sciences was 91.36%. The lowest was 78.58%. And the median was 85.66%.

FRA:87S's Gross Margin % is ranked better than
84.99% of 753 companies
in the Biotechnology industry
Industry Median: 60.8 vs FRA:87S: 90.32

Roivant Sciences had a gross margin of 92.78% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Roivant Sciences was 0.00% per year.


Roivant Sciences Gross Margin % Historical Data

The historical data trend for Roivant Sciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Gross Margin % Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Gross Margin %
91.35 83.78 78.58 87.53

Roivant Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.51 91.19 90.13 84.75 92.78

Competitive Comparison of Roivant Sciences's Gross Margin %

For the Biotechnology subindustry, Roivant Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roivant Sciences's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's Gross Margin % falls into.



Roivant Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Roivant Sciences's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=100.5 / 114.811
=(Revenue - Cost of Goods Sold) / Revenue
=(114.811 - 14.315) / 114.811
=87.53 %

Roivant Sciences's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=47.5 / 51.218
=(Revenue - Cost of Goods Sold) / Revenue
=(51.218 - 3.696) / 51.218
=92.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Roivant Sciences  (FRA:87S) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Roivant Sciences had a gross margin of 92.78% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Roivant Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Roivant Sciences Business Description

Traded in Other Exchanges
Address
50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines